Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2014: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
This study aimed to examine that HLA-specific IgM in lung transplant recipient’s sera can be a reasonable marker for immunological activity of acute rejection. As a methodology for HLA-IgM detection, the Flow PRA method was employed and reasonable detectability was confirmed. HLA-IgM value at the time of development of acute rejection was significantly higher than that of immunologically stable condition. Furthermore, the serum HLA-IgM value was unaffected by nonspecific inflammatory response caused by acute stress of common thoracic surgery. This study indicates that monitoring HLA-IgM can contribute to predicting the development of acute lung transplant rejection and determining optimal immunosuppressive management.
|